Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Discotto

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|June 24, 2005
American Society of Microbiology - 101st General Meeting. 20-24 May 2001, Orlando, FL, USAM J Pucci, L Discotto, J F Barrett
FEMS Microbiology Letters|April 1, 1992
Insertional inactivation of a gene which controls expression of vancomycin resistance on plasmid pHKK100S Handwerger, L Discotto, J Thanassi, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbonesS Weinheimer, L Discotto, J Friborg, et al.
Idrugs : the Investigational Drugs Journal|October 4, 2005
Bacterial resistanceL E Lawrence, M J Pucci, L Discotto, et al.
Journal of Bacteriology|August 28, 1999
Comparison of the D-glutamate-adding enzymes from selected gram-positive and gram-negative bacteriaA W Walsh, P J Falk, J Thanassi, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|June 24, 2005
American Society of Microbiology - 101st General Meeting. 20-24 May 2001, Orlando, FL, USAM J Pucci, L Discotto, J F Barrett
FEMS Microbiology Letters|April 1, 1992
Insertional inactivation of a gene which controls expression of vancomycin resistance on plasmid pHKK100S Handwerger, L Discotto, J Thanassi, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbonesS Weinheimer, L Discotto, J Friborg, et al.
Idrugs : the Investigational Drugs Journal|October 4, 2005
Bacterial resistanceL E Lawrence, M J Pucci, L Discotto, et al.
Journal of Bacteriology|August 28, 1999
Comparison of the D-glutamate-adding enzymes from selected gram-positive and gram-negative bacteriaA W Walsh, P J Falk, J Thanassi, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.
Pageof 1